Barclays stock: Barclays PLC discloses positions in Spire Healthcare and SThree
Published on 10/06/2026 at 18:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Barclays PLC filed Form 8.3 disclosures dated October 6, 2026, covering its positions in Spire Healthcare Group and SThree PLC. The disclosures were published through RNS, the London Stock Exchange's primary information service, and identify Barclays PLC as the discloser. RNS via TradingView
Position disclosures
In the Spire Healthcare Group filing, Barclays reported interests totaling 3.88% and short positions totaling 3.87% in 1p ordinary shares. The filing recorded purchases and sales on October 5, 2026, and was disclosed on October 6, 2026. The RNS filing also states that the disclosure relates to Spire Healthcare Group PLC.
In a separate SThree PLC filing, Barclays reported interests totaling 3.54% and short positions totaling 3.54% in 1p ordinary shares. That disclosure also recorded dealings dated October 5, 2026. The separate RNS filing identifies SThree PLC as the relevant offeree.
Share admission
Barclays PLC said on October 1, 2026, that 2,187,284 ordinary shares had been admitted to trading on the London Stock Exchange's Main Market. The shares carry ISIN GB0031348658 and are fungible with existing shares. The notification covered admissions between September 1 and September 30, 2026. RNS via Investegate
